European Journal of Organic Chemistry p. 510 - 513 (2020)
Update date:2022-08-02
Topics:
Marx, Lisa
Ríos-Lombardía, Nicolás
Süss, Philipp
H?hne, Matthias
Morís, Francisco
González-Sabín, Javier
Berglund, Per
A chemoenzymatic approach has been developed for the preparation of sertraline, an established anti-depressant drug. Ketoreductases (KREDs) were employed to yield a key chiral precursor. The bioreduction of the racemic tetralone exhibited excellent enantioselectivity (>99 % ee) and diastereomeric ratio (99:1) at 29 % conversion (the maximum theoretical yield is 50 %) after 7 hours. The resulting (S,S)-alcohol was efficiently oxidized to an enantiopure (S)-ketone, an immediate precursor of sertraline, by using sodium hypochlorite as oxidant and 2-azaadamantane N-oxyl (AZADO) as organocatalyst. Alternative routes aiming at the direct biocatalytic amination using imine reductases and transaminases were unsuccessful.
View Morewebsite:http://www.hybio.com.cn
Contact:+86 755 26588093
Address:No.9 Linkong West Street, Hengdian Street, Huangpi District, Wuhan City, China.
Contact:+86-21-61318535
Address:Building 29,No.2139 Xizha Road, Fengxian District, Shanghai
MTT Pharma & Bio-technology Co.,Ltd
Contact:+86-21-58407925
Address:Room2019, Building C, Tomson Center, No.158, Zhang Yang Road, Shanghai, China
Xian Changyue Biological Technology Co., Ltd.
website:https://www.xachangyue.com/
Contact:+86-029-62886900
Address:Keji Road NO.70
Henan PURUI Pharmaceutical Co., Ltd.
website:http://www.puruipharm.com
Contact:17739583555
Address:Yezhuangqiao,Xihua town, Henan province
Doi:10.1002/chem.201303699
(2014)Doi:10.1016/S0040-4020(01)85512-5
(1994)Doi:10.1016/j.tetlet.2010.07.100
(2010)Doi:10.1080/15421400490506720
(2004)Doi:10.1248/cpb.58.87
(2010)Doi:10.1016/j.tetlet.2010.07.040
(2010)